🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ARIA can worsen after initial detection. Drs. Bateman and Snider highlight why stopping therapy and reassessing at 4–8 weeks is vital in moderate ARIA cases. Get the clinical tips: ow.ly/qpSA50VI2Ah #Neurology #Alzheimers

Managing metabolic side effects in schizophrenia requires more than lifestyle advice. Dr. Goldberg discusses pharmacologic strategies for weight gain, glucose, and lipids in patients on antipsychotics: ow.ly/uArC50VI2E7 #Psychiatry #Schizophrenia

Want to know how your MS patients are doing between appointments? Patient-reported outcomes offer scalable insights via web platforms. Learn more in this comprehensive program: ow.ly/CQrp50VI2GE #MS #NeuroTwitter

Can the gut microbiome offer early clues to MS? A new multicenter study finds reduced phylogenetic diversity and depletion of SCFA-producing taxa in pediatric-onset MS: ow.ly/JqBF50VI2It #Microbiome #POMS #MultipleSclerosis

Hear Dr. Barakos break down imaging strategy in the emergency setting for patients on anti-amyloid therapy: ow.ly/SvbU50W038U #EmergencyRadiology #NeuroED

Catching #Alzheimers early means more than starting treatment—it means preserving autonomy, engaging families in planning, and offering patients a voice in their care. Learn more about early identification: ow.ly/4gMY50W039a #AlzheimersAwareness

Mini-strokes may be brief, but their effects aren’t. New research shows fatigue can linger for up to a year post-TIA. Rethink post-stroke care: ow.ly/JiUL50W03eB #TIA #Neurology #StrokeRecovery

MS care is more than DMTs. Comorbidities like hypertension and diabetes can speed up progression and reduce treatment efficacy. Learn why a full-body approach matters: ow.ly/NXEu50W03gH #MSCare #BrainHealth #Neurology

Gene therapy is changing the trajectory of Duchenne muscular dystrophy by targeting the genetic root cause, not just the symptoms. Explore recent trial results: ow.ly/2OGV50W03iG #DMD #GeneTherapy #NeuromuscularCare #ClinicalResearch

LGS and Dravet syndrome are rare, complex, and often misdiagnosed, especially in adults. Are you recognizing the signs early? Explore genetic testing and evolving diagnostic criteria: ow.ly/zoB850W5uso #Epilepsy #NeuroTwitter #CME

Physical activity supports brain health through neuroprotective pathways. It's more than fitness—it’s a tool to reduce Alzheimer’s risk. Encouraging movement could protect cognition. Learn more: ow.ly/2NNu50W5uQn #BrainHealth #HealthyAging #CognitiveCare

Some MRI sequences pick up more detail than others. In Alzheimer’s patients starting anti-amyloid therapy, using SWI instead of GRE may reveal more microbleeds. Don't miss these insights: ow.ly/Kc7p50W5v3P #Alzheimers #Neurology #MRI

A new Alzheimer’s drug candidate shows promise in mouse models by reducing toxic brain proteins and boosting protective ones—improving memory at the same time. Dive into this dual action approach: ow.ly/6Yxq50W5vaG #AlzheimersResearch #NeuroScience

Parkinson’s patients often experience “off episodes”—times when their meds wear off and symptoms return. Explore newer treatment options designed to reduce these episodes and improve daily function: ow.ly/BJts50W5vhQ #Parkinsons #NeuroCME #MovementDisorders

New research shows that clusters of ion channels can log voltage history, sustaining neural activity even after stimuli end. This could be key to understanding memory formation. Check out the data: ow.ly/ibic50W5vnn #SynapticPlasticity #NeuroScience

Early recognition of neuropsychiatric symptoms in Alzheimer’s can change outcomes. Join us live on July 30 as we evaluate diagnostic strategies and emerging therapies. Sign up now: ow.ly/C59850WtC6Q #Neurodegeneration #ENDALZ

#StrokeRecovery is evolving. TRIACOG-Online offers remote, rigorous cognitive assessments, while virtual art therapy helps reduce fatigue and increase engagement. Explore how digital tools are enhancing outcomes in real-time stroke rehabilitation: ow.ly/E8iH50WtC8J

Stroke prevention in diabetes goes beyond A1C control. In this expert-led CME, learn how GLP-1 receptor agonists may reduce stroke risk—even in patients with good glycemic control. Dive in now: ow.ly/U2L850WtCam #NeuroTwitter #DiabetesManagement

Gabapentin remains a key tool for neuropathic pain, but frequent use may carry cognitive risks. Observational data link repeated use to dementia. Learn more: ow.ly/4Mmv50WtCbA #Neurology #CognitiveHealth

ARIA isn’t always asymptomatic. When severe symptoms emerge, clinicians must act fast and decisively. Learn how to approach inpatient care, steroid use and difficult treatment conversations.: ow.ly/5Isx50WtCe7 #AmyloidTherapy